Earnings Data
Report Date
Nov 04, 2026TBA (Confirmed)
Period Ending
2026 (Q3)Consensus EPS Forecast
-0.78Last Year’s EPS
-0.73Same Quarter Last Year
Moderate Buy
Based on 13 Analysts Ratings
DE:PV3B Q2 2026 Earnings Report
DE:PV3B Upcoming Earnings
EyePoint Pharmaceuticals's next earnings date is estimated for November 4, 2026, based on past reporting schedules.
DE:PV3B Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DE:PV3B Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 05, 2026 | €10.40 | €9.90 | -4.81% |
May 06, 2026 | €11.60 | €11.40 | -1.72% |
Mar 04, 2026 | €15.27 | €15.09 | -1.18% |
Nov 05, 2025 | €10.29 | €10.38 | +0.83% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does EyePoint Pharmaceuticals Inc (DE:PV3B) report earnings?
EyePoint Pharmaceuticals Inc (DE:PV3B) is schdueled to report earning on Nov 04, 2026, TBA (Confirmed).
What is EyePoint Pharmaceuticals Inc (DE:PV3B) earnings time?
EyePoint Pharmaceuticals Inc (DE:PV3B) earnings time is at Nov 04, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of EyePoint Pharmaceuticals Inc stock?
The P/E ratio of EyePoint Pharmaceuticals is N/A.
What is DE:PV3B EPS forecast?
DE:PV3B EPS forecast for the fiscal quarter 2026 (Q3) is -0.78.